Search Results 1371-1380 of 17142 for monoclonal antibody

  1. Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma - Mayo Clinic

    Positive laboratory test for anti-HIV 1,2; HBsAg, anti-HTLV-I; anti-HCV, or syphilis (Patients with anti-hepatitis B core antibody are eligible if negative for ...

  2. Biological therapy for cancer - Doctors & Departments - Mayo Clinic

    Therapeutic antibodies and immunologic conjugates. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Feb. 10 ...

  3. Loss of smell (anosmia) Causes - Mayo Clinic

    A stuffy nose is one cause of this symptom. Learn about other causes and when it might be serious.

  4. Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors - Mayo Clinic

    Prior treatment with CD137 agonists, anti-CTLA-4 and anti-TIGIT antibodies. History of any Grade 3 or 4 immune-related AE toxicity from prior immunotherapy ...

  5. NanoString GeoMx WTA + Immuno-Oncology Proteome Atlas (IPA) - Spatial Multiomics Core - Mayo Clinic Research Core Facilities

    ... antibody targets that can be analyzed on the same slide or separately. This method requires identifying regions of interest using morphology marker staining ...

  6. Cancer - Doctors and departments - Mayo Clinic

    Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · Myths about cancer causes · No appetite? How to get ...

  7. Bone Marrow Transplant Clinical Trials - Mayo Clinic Research

    Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...

  8. Clinical trials - Oncology (Medical)

    ... antibodies and the factors that may determine disease progression and treatment response. Pagination Clinical studies. PrevPrevious Page · Go to page 2020 · Go ...

  9. Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer - Mayo Clinic

    * Patients with prior hypersensitivity to monoclonal antibodies (mAb) * Women who are pregnant or breastfeeding * Patients who received prior treatment with ...

  10. A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma - Mayo Clinic

    * Has previously received an anti-IL-27 antibody (Ab) or anti-IL-27-targeted therapy. * Has known fibrolamellar HCC histology, sarcomatoid HCC, or mixed ...